المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_material_/24601538Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.s001Test
https://figshare.com/articles/journal_contribution/Supplementary_material_/24601538Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/journal_contribution/PKDL_Sudan_Study_Synopsis_/24601627Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.s002Test
https://figshare.com/articles/journal_contribution/PKDL_Sudan_Study_Synopsis_/24601627Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_of_information_to_include_when_reporting_a_randomised_trial_/24601630Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.s003Test
https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_of_information_to_include_when_reporting_a_randomised_trial_/24601630Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/figure/Fig_1_-/24601636Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.g001Test
https://figshare.com/articles/figure/Fig_1_-/24601636Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/figure/PKDL_lesion_distribution_grade_over_time_by_treatment_arm_mITT_set_/24601642Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.g003Test
https://figshare.com/articles/figure/PKDL_lesion_distribution_grade_over_time_by_treatment_arm_mITT_set_/24601642Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/figure/Median_plasma_and_skin_concentrations_of_miltefosine_on_days_28_and_42_of_paromomycin_on_day_14_and_liposomal_amphotericin_B_on_day_7_/24601645Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.g004Test
https://figshare.com/articles/figure/Median_plasma_and_skin_concentrations_of_miltefosine_on_days_28_and_42_of_paromomycin_on_day_14_and_liposomal_amphotericin_B_on_day_7_/24601645Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/figure/Kaplan-Meier_curve_of_time_to_complete_cure_by_treatment_arm_and_overall_mITT_set_/24601639Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.g002Test
https://figshare.com/articles/figure/Kaplan-Meier_curve_of_time_to_complete_cure_by_treatment_arm_and_overall_mITT_set_/24601639Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/dataset/Baseline_characteristics_by_treatment_arm_and_overall_ITT_set_/24601648Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.t001Test
https://figshare.com/articles/dataset/Baseline_characteristics_by_treatment_arm_and_overall_ITT_set_/24601648Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/dataset/Primary_efficacy_outcome_of_definitive_cure_at_12_months_by_treatment_arm_mITT_and_PP_sets_/24601651Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.t002Test
https://figshare.com/articles/dataset/Primary_efficacy_outcome_of_definitive_cure_at_12_months_by_treatment_arm_mITT_and_PP_sets_/24601651Test

المؤلفون: Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M. Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P. C. Dorlo, Eduard E. Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Virology, Computational Biology, liposomal amphotericin b, future vl elimination, either daily intra, azar dermal leishmaniasis, 2 %, 3 &# 8211, 2 &# 8211, 0 %, 110 patients completed, 0 &# 8211, actual treatment received, grade 3 pkdl, least one dose, plus oral miltefosine, mf &# 8211, additional pkdl treatment, randomized patients receiving, currently recommended 60, 6 %) patients, 12 years old, +treatment%22">xlink "> treatment, safe oral therapies

الوقت: 95

العلاقة: https://figshare.com/articles/dataset/Treatment-emergent_ADRs_by_SOC_and_PT_by_treatment_arm_and_overall_mITT_set_/24601657Test

الإتاحة: https://doi.org/10.1371/journal.pntd.0011780.t004Test
https://figshare.com/articles/dataset/Treatment-emergent_ADRs_by_SOC_and_PT_by_treatment_arm_and_overall_mITT_set_/24601657Test